CAI Caris Life Sciences, Inc.

NASDAQ
$18.54

Caris Life Sciences, Inc. (CAI) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -31.8% since its last earnings release on November 4, 2026.

Caris Life Sciences Beat Consensus Estimates, Raises Guidance
Wednesday, November 4, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $0.05
Rev est $285.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $23.45

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Caris Life Sciences, Inc.

Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare.

Sector

Healthcare

Industry

Medical Labs & Research

Charts powered in part by Lightweight Charts™ by TradingView.